Literature DB >> 7480725

Renal angiomyolipoma: growth followed up with CT and/or US.

L Lemaitre1, Y Robert, F Dubrulle, M Claudon, A Duhamel, P Danjou, E Mazeman.   

Abstract

PURPOSE: To follow up the growth of renal angiomyolipomas (AMLs).
MATERIALS AND METHODS: Patients with known AML (n = 55) were divided into three groups on the basis of initial clinical and computed tomographic (CT) findings: group 1, isolated AML (n = 43); group 2, multiple AMLs without tuberous sclerosis (TS) (n = 6); group 3, multiple AMLs with TS (n = 6). Follow-up ultrasonography (US) and CT were performed in 55 and 31 patients, respectively. Growth of the AMLs (n = 59) was evaluated on the basis of area on initial and follow-up images.
RESULTS: Mean percentage growth was 17%, 128%, and 47%, and mean growth rate per year was 5%, 22%, and 18% in groups 1, 2, and 3, respectively. New renal lesions were noted in three patients in groups 1 and 2, but no new lesions were detected in group 3, because of the large number of AMLs. New extrarenal lesions were observed in four, two, and three patients in groups 1, 2, and 3, respectively. No correlation was found between percentage of fatty tissue and growth rate.
CONCLUSION: Multiple AMLs show more growth than solitary AMLs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7480725     DOI: 10.1148/radiology.197.3.7480725

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  16 in total

Review 1.  Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms.

Authors:  S Johnson
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

Review 2.  Tuberous sclerosis complex: the past and the future.

Authors:  Liesbeth De Waele; Lieven Lagae; Djalila Mekahli
Journal:  Pediatr Nephrol       Date:  2014-12-23       Impact factor: 3.714

Review 3.  Clinical and molecular insights into tuberous sclerosis complex renal disease.

Authors:  Brian J Siroky; Hong Yin; John J Bissler
Journal:  Pediatr Nephrol       Date:  2010-12-09       Impact factor: 3.714

Review 4.  Tuberous sclerosis complex: neurological, renal and pulmonary manifestations.

Authors:  D N Franz; J J Bissler; F X McCormack
Journal:  Neuropediatrics       Date:  2011-01-05       Impact factor: 1.947

5.  Computed tomographic distinction of perirenal liposarcoma from exophytic angiomyolipoma: a feature analysis study.

Authors:  James J Ellingson; Fergus V Coakley; Bonnie N Joe; Aliya Qayyum; Antonio C Westphalen; Benjamin M Yeh
Journal:  J Comput Assist Tomogr       Date:  2008 Jul-Aug       Impact factor: 1.826

6.  Transcatheter embolisation of renal angiomyolipoma.

Authors:  S Leong; A N Keeling; F P McGrath; M J Lee
Journal:  Ir J Med Sci       Date:  2009-07-18       Impact factor: 1.568

7.  T-cell co-regulatory molecule expression in renal angiomyolipoma and pulmonary lymphangioleiomyomatosis.

Authors:  Stephen A Boorjian; Yuri Sheinin; Paul L Crispen; Christine M Lohse; Bradley C Leibovich; Eugene D Kwon
Journal:  Urology       Date:  2009-06-07       Impact factor: 2.649

8.  Hormone receptor expression in renal angiomyolipoma: clinicopathologic correlation.

Authors:  Stephen A Boorjian; Yuri Sheinin; Paul L Crispen; Christine M Lohse; Eugene D Kwon; Bradley C Leibovich
Journal:  Urology       Date:  2008-03-28       Impact factor: 2.649

9.  Long-term results of preventive embolization of renal angiomyolipomas: evaluation of predictive factors of volume decrease.

Authors:  A Hocquelet; F Cornelis; Y Le Bras; M Meyer; E Tricaud; A S Lasserre; J M Ferrière; G Robert; N Grenier
Journal:  Eur Radiol       Date:  2014-06-03       Impact factor: 5.315

Review 10.  Renal involvement in tuberous sclerosis complex and von Hippel-Lindau disease: shared disease mechanisms?

Authors:  Brian J Siroky; Maria F Czyzyk-Krzeska; John J Bissler
Journal:  Nat Clin Pract Nephrol       Date:  2009-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.